This study aimed to investigate the efficacy of Agens 128 in treating chronic inflammation in a preclinical model. Traditional therapies for chronic inflammation often come with side effects or limited effectiveness. Therefore, there is a growing interest in exploring novel treatments, such as Agens 128, a new compound with anti-inflammatory properties. Introduction Chronic inflammation is a common underlying factor for various diseases, such as rheumatoid arthritis, Crohn's disease, and cardio...